Results 111 to 120 of about 624,402 (215)

Role of PAX-8, CD5, and CD117 in Distinguishing Thymic Carcinoma From Poorly Differentiated Lung Carcinoma

, 2014
Aim:To determine if PAX-8, CD5, and CD117 can differentiate thymic carcinoma from poorly differentiated lung carcinoma.Design:Archived cases of thymic (n=13) and poorly differentiated lung (n=15) carcinoma were analyzed for intensity and proportion of ...
Asirvatham, J. R., Bhuiya, T. A., Esposito, M. J.   +2 more
core   +1 more source

A rare case of tumor‐to‐tumor metastasis from thymic carcinoma to an ovarian mature teratoma

Thoracic Cancer
Metastasis from one neoplasm to another is referred to as tumor‐to‐tumor metastasis (TTM). TTM is rarely observed. Here, we present a patient with TTM from a thymic carcinoma to an ovarian mature teratoma. A 25‐year‐old woman, diagnosed with unresectable
Tsuyoshi Sasada, Chigusa Shirakawa, Ryo Tachikawa, Daisuke Yamashita, Keisuke Tomii   +4 more
doaj   +1 more source

Investigating the impact of tumor size on survival outcomes in thymoma and thymic carcinoma patients using the SEER database

Scientific Reports
This study aims to clarify the impact of tumor size on the prognosis of patients diagnosed with thymoma and thymic carcinoma, leveraging data from a population-based registry.
Yipeng Yin, Wei Wang, Mingbo Tang, Wei Liu   +3 more
doaj   +1 more source

Prognostic Factors and Efficacy of First-Line Chemotherapy in Patients with Advanced Thymic Carcinoma: A Retrospective Analysis of 286 Patients from NEJ023 Study

, 2018
BACKGROUND: The prognostic factors and the efficacy of first-line chemotherapy remain unclear in patients with advanced thymic carcinoma. MATERIALS AND METHODS: We conducted a multi-institutional retrospective study named NEJ023 for patients with ...
Sugiyama, Tomohide, Ko, Ryo, Iwasawa, Shunichiro, Yamasaki, Masahiro, Okuma, Yusuke, Muraki, Keiko, Fujiwara, Akiko, Shukuya, Takehito, Imai, Hisao, Miyauchi, Eisaku, Tanaka, Hisashi, Takashima, Yuta, Tateishi, Kazunari, Azuma, Keisuke, et al.   +14 more
core   +1 more source

Thymic carcinomas

, 2018
Thymic carcinomas (TC) are approximately 10 times less prevalent than thymomas but of high clinical relevance because they are more aggressive, less frequently resectable than thymomas and usually refractory to classical and targeted long-term treatment approaches.
Stroebel, Philipp, Weis, C.-A., Marx, A.
openaire   +1 more source

Definitive chemoradiotherapy with Carboplatin Plus Paclitaxel for Unresectable Locally Advanced Thymic Carcinoma: A case series

Current Problems in Cancer: Case Reports
Objectives: Thymic carcinoma (TC) is rare. There is no evidence regarding the treatment strategies for unresectable locally advanced thymic carcinomas. Definitive chemoradiotherapy may treat this condition. However, an appropriate concurrent chemotherapy
Koichiro Nozaki, Satoshi Watanabe, Ryo Yamazaki, Masashi Arita, Toshiaki Kikuchi   +4 more
doaj   +1 more source

Thymic Carcinoma with Brain Metastasis Mimicking Meningioma

, 2002
Thymic carcinoma is a rare malignancy, which differs from thymoma in that it displays histopathologically malignant features, extensive local invasion, and a substantial potential for metastasis, predominantly to the liver and kidney and rarely to the ...
안정용
core   +1 more source

NUT Midline Carcinoma Masquerading As a Thymic Carcinoma

, 2016
Thymic carcinomas are rare tumors that arise from the epithelium of the thymus gland and characterized by cytologic atypia, invasiveness, and high risk of relapse and death.1–3 The current WHO schema recognizes at least 11 histologic subtypes.4–7 ...
Loehrer, Patrick J., Sr., Kesler, Kenneth, Badve, Sunil, Gökmen-Polar, Yesim   +3 more
core   +1 more source

Tumour dimension is a prognostic factor in thymic epithelial tumours : an update analysis from the ESTS thymic database: tumour dimension in thymic tumours

: Objective: The 9thTNM proposal for thymic epithelial tumours (TETs) introduced size as category in stage I, confirming tumour infiltration type as descriptor for the other stages.
Mendogni, Paolo, Guerrera, Francesco, Londero, Francesco, Trancho, Florentino Hernan, Ruffini, Enrico, Novoa, Nuria Maria, Barmin, Vitaly, Casiraghi, Monica, Bravio, Ivan, Moser, Bernhard, Menghesha, Hruy, Venuta, Federico, Voulaz, Emanuele, Furak, Jozsef, Podobed, Alexandr, Campanella, Annalisa, Chiappetta, Marco, Cafarotti, Stefano, Santoro, Gloria, Zisis, Charalambros, Voltolini, Luca, Sassorossi, Carolina, Liberman, Moishe, Opitz, Isabelle, Lococo, Filippo, Bille, Andrea, van Schil, Paul, Margaritora, Stefano   +27 more
core  

Poor efficacy of immune checkpoint inhibitor treatment in advanced thymic carcinoma patients with liver metastases

Therapeutic Advances in Medical Oncology
Background: Although immune checkpoint inhibitor treatment for advanced thymic carcinoma exhibits promising efficacy, factors that affect the efficacy and prognosis, including metastases sites, remain uncertain. Objectives: Our study aimed to investigate
Yue Hao, Manyi Xu, Xiaohong Zeng, Yina Wang, Wenxian Wang, Gen Lin, Bihui Li, Jianhui Huang, Chunwei Xu, Yongchang Zhang, Zhengbo Song   +10 more
doaj   +1 more source